31 years survival rate of ARPE® single-mobility prosthesis in trapeziometacarpal osteoarthritis.

A retrospective study of 41 trapeziometacarpal prostheses showed that the implant survival rate decreased linearly over time with a critical period in the first years; ranging from 83% after 5 years to 50% after 30 years. Level of evidence: IV.